Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mike Baldwin

Cost-Effectiveness of Tiotropium Versus Glycopyrronium in Moderate to Very Severe Chronic Obstructive Pulmonary Disease in Canada, Spain, Sweden, and the UK

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2016English

Related publications

Prs42 - Cost-Effectiveness of Indacaterol/Glycopyrronium in the Treatment of Chronic Obstructive Pulmonary Disease in Brazil

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of Indacaterol/Glycopyrronium in Comparison With Salmeterol/Fluticasone Combination for Patients With Moderate-To-Severe Chronic Obstructive Pulmonary Disease: A LANTERN Population Analysis From Singapore

Singapore Medical Journal
Medicine
2018English

Differences in Symptom Burden Among Patients With Moderate, Severe, or Very Severe Chronic Obstructive Pulmonary Disease

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2016English

Long-Term Safety Study of Infliximab in Moderate-To-Severe Chronic Obstructive Pulmonary Disease

Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Cost-Effectiveness Analysis of Baricitinib Versus Adalimumab for the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Spain

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2019English

Tiotropium Respimat® Improves Physical Functioning in Chronic Obstructive Pulmonary Disease

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2010English

Daily Home-Based Spirometry During Withdrawal of Inhaled Corticosteroid in Severe to Very Severe Chronic Obstructive Pulmonary Disease

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2016English

Long-Acting Beta2-Agonist in Addition to Tiotropium Versus Either Tiotropium or Long-Acting Beta2-Agonist Alone for Chronic Obstructive Pulmonary Disease

Cochrane Database of Systematic Reviews
2015English

Cost-Effectiveness of Glycopyrronium Compared to Tiotropium in COPD Patients From a Swedish Societal Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy